FDA inspection
SGS North America Inc.: FDA inspection ending Feb 14, 2017
FDA inspection 1001725 · No Action Indicated (NAI) · Lincolnshire, IL
Key facts
| Inspection ID | 1001725 |
|---|---|
| Firm | SGS North America Inc. |
| FEI number | 1418028 |
| Address | 616 Heathrow Dr |
| City | Lincolnshire |
| State | IL |
| ZIP | 60069 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Feb 14, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data